Innovative drugs bring continuous benefits to cancer patients
Author:
Publisher
Innovation Press Co., Limited
Reference5 articles.
1. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646?674.
Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646?674.
2. Hong, D.S., Fakih, M.G., Strickler, J.H., et al. (2020). KRASG12C inhibition with sotorasib in advanced solid tumors. N Engl J Med 383, 1207?1217.
Hong, D.S., Fakih, M.G., Strickler, J.H., et al. (2020). KRASG12C inhibition with sotorasib in advanced solid tumors. N Engl J Med 383, 1207?1217.
3. Zeidan, A.M., Al-Kali, A., Borate, U., et al. (2021). Sabatolimab (MBG453) combination treatment regimens for patients (Pts) with higher-risk myelodysplastic syndromes (HR-MDS): the MDS studies in the stimulus immuno-myeloid clinical trial program. Blood 138 (Supplement 1) , 4669.
Zeidan, A.M., Al-Kali, A., Borate, U., et al. (2021). Sabatolimab (MBG453) combination treatment regimens for patients (Pts) with higher-risk myelodysplastic syndromes (HR-MDS): the MDS studies in the stimulus immuno-myeloid clinical trial program. Blood 138 (Supplement 1) , 4669.
4. Tsurutani, J., Iwata, H., Krop, I., et al. (2020). Targeting HER2 with trastuzumab deruxtecan: a dose-expansion, phase I study in multiple advanced solid tumors. Cancer Discov 10, 688?701.
Tsurutani, J., Iwata, H., Krop, I., et al. (2020). Targeting HER2 with trastuzumab deruxtecan: a dose-expansion, phase I study in multiple advanced solid tumors. Cancer Discov 10, 688?701.
5. Nathan, P., Hassel, J.C., Rutkowski, P., et al. (2021). Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med 385, 1196?1206.
Nathan, P., Hassel, J.C., Rutkowski, P., et al. (2021). Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med 385, 1196?1206.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma;The Innovation;2024-07
2. Two new jatrophane diterpenoids from Euphorbia helioscopia with activity towards autophagic flux;Journal of Asian Natural Products Research;2024-05-16
3. Corydecusines A-H, new phthalideisoquinoline hemicetal alkaloids from the bulbs of Corydalis decumbens inhibit Tau pathology by activating autophagy mediated by AMPK-ULK1 pathway;Bioorganic Chemistry;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3